XML 71 R20.htm IDEA: XBRL DOCUMENT v2.3.0.15
Segment Information
9 Months Ended
Sep. 30, 2011
Segment Information 
Segment Information

NOTE 12. SEGMENT INFORMATION

During the fourth quarter of 2010, the Company changed the composition of its reportable segments to reflect changes in its internal organization resulting from the rate of growth within certain of the Company's businesses and the contribution of certain of the Company's tool manufacturing and distribution businesses to the Apex joint venture. The Company now reports results in five separate business segments consisting of the Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental; and Industrial Technologies segments. In addition, the historical results of the tool related business and the Company's equity in earnings of the Apex joint venture is shown separately in the Company's segment disclosures. There has been no material change in total assets or liabilities by segment since December 31, 2010, except for the addition of Beckman Coulter, Inc. to the Life Sciences & Diagnostics segment effective June 25, 2011 and the sale of the Pacific Scientific Aerospace business from the Industrial Technologies segment on April 21, 2011. Segment results for the three and nine months ended September 30, 2011 and October 1, 2010 are shown below ($ in millions):

 

     Three Months Ended     Nine Months Ended  
     September 30,
2011
    October 1,
2010
    September 30,
2011
    October 1,
2010
 

Sales:

        

Test & Measurement

   $ 856.7      $ 697.2      $ 2,535.4      $ 2,031.5   

Environmental

     734.6        678.6        2,133.2        1,986.3   

Life Sciences & Diagnostics

     1,567.4        559.8        2,898.8        1,616.4   

Dental

     492.6        443.0        1,460.8        1,303.1   

Industrial Technologies

     866.8        714.2        2,547.3        2,065.2   

Businesses contributed to Apex joint venture attributable to periods prior to contribution

     —          —          —          315.6   
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 4,518.1      $ 3,092.8      $ 11,575.5      $ 9,318.1   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating Profit:

        

Test & Measurement

   $ 205.2      $ 145.0      $ 567.6      $ 414.1   

Environmental

     158.5        143.4        445.8        398.0   

Life Sciences & Diagnostics

     52.1        69.1        177.0        138.3   

Dental

     71.5        57.3        176.0        140.1   

Industrial Technologies

     187.2        151.4        549.3        421.4   

Businesses contributed to Apex joint venture:

        

Attributable to period prior to contribution

     —          —          —          41.5   

Equity method earnings subsequent to JV formation

     16.0        10.6        44.9        10.6   

Other

     (34.4     (23.7     (87.8     (71.6
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 656.1      $ 553.1      $ 1,872.8      $ 1,492.4